Cargando…

Angiotensin-converting enzyme inhibitors will not help in improving stroke outcome if given immediately after stroke

Detalles Bibliográficos
Autor principal:	Bhatia, Rohit
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Debates in Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981749/ https://www.ncbi.nlm.nih.gov/pubmed/21085522 http://dx.doi.org/10.4103/0972-2327.70871

Ejemplares similares

Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke
por: Padma, M. V.
Publicado: (2010)

Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary
por: Kaul, Subhash
Publicado: (2010)

Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020)

Angiotensin-converting enzyme gene insertion/deletion polymorphism and risk of ischemic stroke complication among patients with hypertension in the Ethiopian population
por: Melake, Addisu, et al.
Publicado: (2023)

Corrigendum: Angiotensin-converting enzyme gene insertion/deletion polymorphism and risk of ischemic stroke complication among patients with hypertension in the Ethiopian population
por: Melake, Addisu, et al.
Publicado: (2023)

Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?
por: Brooks, John M., et al.
Publicado: (2018)

Angiotensin-converting enzyme insertion/deletion gene polymorphism and the progression of cerebral microbleeds
por: Yoon, Cindy W., et al.
Publicado: (2023)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
por: Bonarjee, Vernon VS, et al.
Publicado: (2001)

Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke
por: Stankovic, Sanja, et al.
Publicado: (2011)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection
por: Mehboob, Riffat, et al.
Publicado: (2023)

Microbicide research in developing countries: have we given the ethical concerns due consideration?
por: Moodley, Keymanthri
Publicado: (2007)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke
por: Bennion, Douglas M, et al.
Publicado: (2016)

Improving utilization of and retention in PMTCT services: Can behavioral economics help?
por: Taylor, Nicholas Kenji, et al.
Publicado: (2013)

No space left for intravenous thrombolysis in acute stroke: CONS
por: Muir, Keith
Publicado: (2016)

Editorial: Outcomes of stroke: prediction and improvement
por: Chu, Heling, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
por: Jaki, Thomas, et al.
Publicado: (2018)

Legal medicine implications in fibrinolytic therapy of acute ischemic stroke
por: Sabau, Monica, et al.
Publicado: (2019)

Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy
por: Stalens, Caroline, et al.
Publicado: (2021)

Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors
por: Caballero, Julio
Publicado: (2020)

Structure and Function of Angiotensin Converting Enzyme and Its Inhibitors
por: Zhao, Yulan, et al.
Publicado: (2008)

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
por: Yu, Zhiyin, et al.
Publicado: (2023)

Bimanual training in stroke: How do coupling and symmetry-breaking matter?
por: Sleimen-Malkoun, Rita, et al.
Publicado: (2011)

Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats
por: Brambilla, Marta, et al.
Publicado: (2018)

Angiotensin-Converting Enzyme Inhibitor, Captopril, Improves Scar Healing in Hypertensive Rats
por: Rha, Eun Young, et al.
Publicado: (2021)

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
por: Hieber, Maren, et al.
Publicado: (2019)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01foc6r3egskdntqsb3qes1s99